Japan's TRG-035 drug targets tooth regrowth proteins in human trials, offering hope for dental replacement beyond implants by 2030.
Toregem BioPharma has secured $5.3 million to advance its experimental tooth-regeneration drug, TRG035, into Phase II clinical trials. The drug targets a protein that suppresses tooth growth, aiming ...
Add Yahoo as a preferred source to see more of our stories on Google. Image: Gadget Review Viral TikToks promising “pills that regrow teeth” flood your feed faster than you can fact-check them.